Novel agent filanesib combination therapy for R/R multiple myeloma - 101793

Spotlight
Video

Novel agent filanesib combination therapy for R/R multiple myeloma

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: Filanesib is a novel agent that has previously shown clinical activity in pretreated multiple myeloma (MM) patients. In this interview, Enrique Ocio, MD, PhD, from University Hospital of Salamanca, Salamanca, Spain, gives us an overview of the Phase Ib/II trial (NCT02384083), which evaluated filanesib in combination with pomalidomide and dexamethasone in relapsed/refractory MM. This interview was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.
Shared By : VJHemOnc
Posted on : 02/06/18
Added : 10 months ago
Category : Multiple Myeloma